A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)

• Status: Unknown status
• Trial end date: 2020-12-31

Summary

To evaluate the efficacy and safety of Kangfu Xiaoyan Suppository in the treatment of pelvic inflammatory diseases (dampness-heat accumulation syndrome) and its influence on the sequelae of pelvic inflammatory diseases, and to study the role of traditional Chinese medicine in reducing the use of antibiotics and the risk of clinical medication, taking levofloxacin + metronidazole as the control drug.

• Phase: Phase 4

Details

• Lead Sponsor: China Academy of Chinese Medical Sciences
• Collaborators: Beijing Obstetrics and Gynecology Hospital; Chengdu University of Traditional Chinese Medicine; First Affiliated Hospital of Heilongjiang University of Traditional Chinese; First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; Longhua Hospital; Peking Union Medical College Hospital; Peking University First Hospital; Shenzhen Maternal and Child Health Hospital; Third Hospital of Peking University; Xiyuan Hospital of China Academy of Chinese Medical Sciences
• Treatments: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular